1. A randomized, placebo‐controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1. Issue 8 (15th December 2014) Authors: Tatum, H.; Thuluvath, P. J.; Lawitz, E.; Martorell, C.; DeMicco, M.; Cohen, S.; Rustgi, V.; Ravendhran, N.; Ghalib, R.; Hanson, J.; Zamparo, J.; Zhao, J.; Cooney, E.; Treitel, M.; Hughes, E. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 8(2015) Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗